USD 0.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.75 Million USD | -46.79% |
2022 | 3.3 Million USD | -59.64% |
2021 | 8.18 Million USD | 154.43% |
2020 | 3.21 Million USD | -13.04% |
2019 | 3.7 Million USD | 202.42% |
2018 | 1.22 Million USD | -77.86% |
2017 | 5.52 Million USD | 47643.33% |
2016 | 11.58 Thousand USD | -99.76% |
2015 | 4.84 Million USD | 1474.0% |
2014 | 307.59 Thousand USD | 156.46% |
2013 | 119.94 Thousand USD | 3500.75% |
2012 | 3331.00 USD | -51.73% |
2011 | 6901.00 USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 86.00 USD | -99.83% |
2008 | 49.45 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 250 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 63.57 Thousand USD | -96.27% |
2024 Q1 | 1.64 Million USD | -1.94% |
2024 Q2 | 1.7 Million USD | 2570.88% |
2023 Q2 | 1.95 Million USD | -36.83% |
2023 Q1 | 3.09 Million USD | -6.33% |
2023 FY | 1.75 Million USD | -46.79% |
2023 Q3 | 1.85 Million USD | -5.3% |
2023 Q4 | 1.75 Million USD | -5.04% |
2022 Q2 | 12.75 Million USD | 307.04% |
2022 Q4 | 3.3 Million USD | -74.84% |
2022 FY | 3.3 Million USD | -59.64% |
2022 Q1 | 3.13 Million USD | -61.74% |
2022 Q3 | 13.13 Million USD | 2.98% |
2021 FY | 8.18 Million USD | 154.43% |
2021 Q3 | 2.09 Million USD | 1.47% |
2021 Q4 | 8.18 Million USD | 291.15% |
2021 Q1 | 3.09 Million USD | -3.93% |
2021 Q2 | 2.06 Million USD | -33.27% |
2020 Q2 | 3.67 Million USD | 2.66% |
2020 Q4 | 3.21 Million USD | -6.53% |
2020 FY | 3.21 Million USD | -13.04% |
2020 Q3 | 3.44 Million USD | -6.35% |
2020 Q1 | 3.58 Million USD | -3.23% |
2019 FY | 3.7 Million USD | 202.42% |
2019 Q1 | 1.2 Million USD | -1.57% |
2019 Q2 | 1.21 Million USD | 0.92% |
2019 Q3 | 1.78 Million USD | 47.21% |
2019 Q4 | 3.7 Million USD | 106.82% |
2018 Q4 | 1.22 Million USD | -25.1% |
2018 Q3 | 1.63 Million USD | -1.23% |
2018 Q2 | 1.65 Million USD | -69.2% |
2018 Q1 | 5.37 Million USD | -2.85% |
2018 FY | 1.22 Million USD | -77.86% |
2017 Q1 | - USD | -100.0% |
2017 Q4 | 5.52 Million USD | 1386.22% |
2017 Q3 | 371.99 Thousand USD | 4458.23% |
2017 Q2 | 8161.00 USD | 0.0% |
2017 FY | 5.52 Million USD | 47643.33% |
2016 FY | 11.58 Thousand USD | -99.76% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | 11.58 Thousand USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | 4.84 Million USD | 1474.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | 307.59 Thousand USD | 12.82% |
2015 Q2 | - USD | -100.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | 307.59 Thousand USD | 156.46% |
2014 Q3 | 247.16 Thousand USD | 26.43% |
2014 Q1 | 119.94 Thousand USD | -73.32% |
2014 Q4 | 272.64 Thousand USD | 10.31% |
2014 Q2 | 195.49 Thousand USD | 63.0% |
2013 FY | 119.94 Thousand USD | 3500.75% |
2013 Q4 | 449.57 Thousand USD | 13396.76% |
2013 Q3 | 3331.00 USD | -94.1% |
2013 Q2 | 56.48 Thousand USD | 1595.59% |
2013 Q1 | 3331.00 USD | 0.0% |
2012 Q4 | 3331.00 USD | 0.0% |
2012 Q2 | 4631.00 USD | -32.89% |
2012 Q1 | 6901.00 USD | 0.0% |
2012 FY | 3331.00 USD | -51.73% |
2012 Q3 | - USD | -100.0% |
2011 Q4 | - USD | -100.0% |
2011 Q2 | 21.57 Thousand USD | 0.0% |
2011 Q1 | - USD | -100.0% |
2011 Q3 | 1901.00 USD | -91.19% |
2011 FY | 6901.00 USD | 0.0% |
2010 Q1 | 86.00 USD | -95.48% |
2010 FY | - USD | -100.0% |
2010 Q4 | 33.53 Thousand USD | -15.51% |
2010 Q3 | 39.68 Thousand USD | 207.49% |
2010 Q2 | 12.9 Thousand USD | 14908.14% |
2009 Q4 | 1901.00 USD | -29.72% |
2009 FY | 86.00 USD | -99.83% |
2009 Q1 | 49.45 Thousand USD | -37.27% |
2009 Q2 | 57.44 Thousand USD | 16.16% |
2009 Q3 | 2705.00 USD | -95.29% |
2008 Q4 | 78.84 Thousand USD | 1.99% |
2008 Q1 | - USD | -100.0% |
2008 Q2 | 1901.00 USD | 0.0% |
2008 FY | 49.45 Thousand USD | 0.0% |
2008 Q3 | 77.3 Thousand USD | 3966.54% |
2007 Q2 | 1901.00 USD | 0.0% |
2007 Q4 | 1901.00 USD | 0.0% |
2007 Q1 | - USD | -100.0% |
2007 Q3 | 1901.00 USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | 1901.00 USD | 0.0% |
2006 Q3 | 1901.00 USD | 0.0% |
2006 Q2 | 1901.00 USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | -100.0% |
2005 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 FY | 250 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.34 Billion USD | 99.869% |
Addus HomeCare Corporation | 124.13 Million USD | 98.583% |
AirSculpt Technologies, Inc. | 69.5 Million USD | 97.47% |
Amedisys, Inc. | 346.76 Million USD | 99.493% |
American Oncology Network, Inc. | 120.44 Million USD | 98.54% |
Astrana Health, Inc. | 296.26 Million USD | 99.406% |
Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 99.862% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 106.63 Million USD | 98.351% |
Cryo-Cell International, Inc. | 9.28 Million USD | 81.053% |
Cross Country Healthcare, Inc. | 2.66 Million USD | 33.961% |
COMPASS Pathways plc | 28.75 Million USD | 93.885% |
DocGo Inc. | 15.16 Million USD | 88.401% |
The Ensign Group, Inc. | 1.78 Billion USD | 99.901% |
Healthcare Services Group, Inc. | 11.23 Million USD | 84.347% |
InnovAge Holding Corp. | 100.49 Million USD | 98.25% |
Assure Holdings Corp. | 505 Thousand USD | -248.241% |
The Joint Corp. | 2 Million USD | 12.069% |
LifeStance Health Group, Inc. | 280.28 Million USD | 99.373% |
Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -361.048% |
ModivCare Inc. | 983.75 Million USD | 99.821% |
NewGenIvf Group Limited | 118.97 Thousand USD | -1378.089% |
Option Care Health, Inc. | 1.05 Billion USD | 99.834% |
P3 Health Partners Inc. | 108.31 Million USD | 98.376% |
P3 Health Partners Inc. | 108.31 Million USD | 98.376% |
The Pennant Group, Inc. | 312.51 Million USD | 99.437% |
Surgery Partners, Inc. | 2.03 Billion USD | 99.914% |
Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 86.82 Million USD | 97.975% |
The Oncology Institute, Inc. | 86.82 Million USD | 97.975% |